@FierceMedDev: Roche chases FDA cancer indication for HPV diagnostic. Story | Follow @FierceMedDev
@MarkHFierce: Duke has found early promise with a blood Dx that predicts aspirin treatment success. Report | Follow @MarkHFierce
@DamianFierce: Patient lawsuits mount as India tries to crack down on unethical clinical trials. Item | Follow @DamianFierce
> Natus Medical ($BABY) has scaled back its second-quarter revenue projections by about 9%, expecting up to $82 million thanks to weak international sales. Release
> Terumo has started selling BSD Medical's ($BSDM) MicroThermX ablation system in Europe, following a licensing deal the two struck in the spring. News
> Diagnostics outfit GeneCentric has raised $2.5 million to develop cancer tests. Article
> Life Care Medical Devices has signed up with M.E.D. Surgical to distribute its Keyhole Cup laparoscopic access device in Ireland. Item
> Game developers are designing programs designed to treat mental disorders like depression and anxiety, but none has been approved by the FDA. Story
> Startup HeadSense has secured an undisclosed amount of financing to develop its non-invasive brain monitor for intracranial pressure. More
> Johns Hopkins physicians successfully used an endoscopy procedure to place a small metal stent in the stomach to treat patients who suffer from gastroparesis-related health problems. Item
> BD ($BDX) named Christopher Reidy as its new chief financial officer, a veteran ADP executive who also held similar roles at AT&T and Deloitte & Touche. Release
Biotech News
@FierceBiotech: SEC hunting down traders who made a quick killing on Onyx shares. Report | Follow @FierceBiotech
@JohnCFierce: Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. News | Follow @JohnCFierce
@RyanMFierce: For those of you who remember Son of Lantus, watch out for Lantus' fraternal (not identical) twin from Lilly and Boehringer. | Follow @RyanMFierce
@EmilyMFierce: Cholera is altering the human genome. Story | Follow @EmilyMFierce
> Swiss biotech OncoEthix snags $19M round to back leukemia drug study. More
> Cytokinetics shares slide on dosing snafu in ALS drug study. Article
> Top Novartis blockbuster prospect whips Enbrel in psoriasis showdown. Story
Pharma News
@FiercePharma: Cost watchdogs veto Novartis breast cancer med Afinitor. NICE says "disappointed" data isn't stronger. News | Follow @FiercePharma
> Roche bids for broad use of HPV test to screen for cervical cancer. Story
> Lilly's Lechleiter returns to CEO suite after surgery. More
> Vivus, FMC both tout proxy advisers' support for board nominees. Article
> Medicare won't pay for Eli Lilly Alzheimer's agent. News
CRO News
> Report: Academia could better use CROs for early research. News
> Lawsuits mount as India pushes trial reforms. Article
> CRO Blue Sky taps new CEO amid growth. Story
> Parexel teams with Rutgers for clinical trials. More
> CROs shift as early-phase demand dries up. News
Biotech IT News
> Report: Pharma execs warm to med reminder apps. News
> GE, Accenture back analytics provider in $20M financing. Article
> Bioinformatics gives U. Wisconsin team an 'edge' in cystic fibrosis study. Story
> AstraZeneca snaps up drug-discovery software from Cambridge startup. More
> Facebook, Twitter bolster Canadian biotech's research of Crohn's therapy. News